Avraham Shemesh - CREMECOMTRSBI Director

WY52 Stock  EUR 0.16  0.04  33.33%   

Insider

Avraham Shemesh is Director of CREMECOMTRSBI DL 001 since 2014.
Age 57
Tenure 10 years
Phone972-349-3200
Webhttp://www.cimcommercial.com

Avraham Shemesh Latest Insider Activity

Tracking and analyzing the buying and selling activities of Avraham Shemesh against CREMECOMTRSBI stock is an integral part of due diligence when investing in CREMECOMTRSBI. Avraham Shemesh insider activity provides valuable insight into whether CREMECOMTRSBI is net buyers or sellers over its current business cycle. Note, CREMECOMTRSBI insiders must abide by specific rules, including filing SEC forms every time they buy or sell CREMECOMTRSBI'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

CREMECOMTRSBI Management Efficiency

The company has return on total asset (ROA) of 0.0151 % which means that it generated a profit of $0.0151 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.014 %, meaning that it generated $0.014 on every $100 dollars invested by stockholders. CREMECOMTRSBI's management efficiency ratios could be used to measure how well CREMECOMTRSBI manages its routine affairs as well as how well it operates its assets and liabilities.
CREMECOMTRSBI DL 001 has accumulated 260.72 M in total debt with debt to equity ratio (D/E) of 0.64, which is about average as compared to similar companies. CREMECOMTRSBI DL 001 has a current ratio of 7.13, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist CREMECOMTRSBI until it has trouble settling it off, either with new capital or with free cash flow. So, CREMECOMTRSBI's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CREMECOMTRSBI DL 001 sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CREMECOMTRSBI to invest in growth at high rates of return. When we think about CREMECOMTRSBI's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Emil HenryEasterly Government Properties
58
Cynthia FisherEasterly Government Properties
58
BSc BScGreat Portland Estates
N/A
Olivia SnyderOffice Properties Income
N/A
Ronald KendallEasterly Government Properties
64
ACA LLBGreat Portland Estates
N/A
Jennifer ClarkOffice Properties Income
62
Carrie HeissGreat Portland Estates
N/A
MIOSH AIEMAGreat Portland Estates
N/A
Matthew BrownOffice Properties Income
41
Alison BernardEasterly Government Properties
33
Kevin BarryOffice Properties Income
N/A
Darren LLBGreat Portland Estates
N/A
William BinnieEasterly Government Properties
61
Darrell CrateEasterly Government Properties
52
Tara InnesEasterly Government Properties
61
Christopher BilottoOffice Properties Income
45
ACA ACAGreat Portland Estates
49
Michael IbeEasterly Government Properties
72
MA MAGreat Portland Estates
54
Dan MAGreat Portland Estates
N/A
CIM Commercial is a real estate investment trust that primarily acquires, owns, and operates Class A and creative office assets in vibrant and improving metropolitan communities throughout the United States . CIM Commercial is operated by affiliates of CIM Group, L.P., a vertically-integrated owner and operator of real assets with multi-disciplinary expertise and in-house research, acquisition, credit analysis, development, finance, leasing, and onsite property management capabilities. CIM COMM operates under REITOffice classification in Germany and is traded on Frankfurt Stock Exchange. It employs 4 people. CREMECOMTRSBI DL 001 (WY52) is traded on Frankfurt Exchange in Germany and employs 5 people.

Management Performance

CREMECOMTRSBI DL 001 Leadership Team

Elected by the shareholders, the CREMECOMTRSBI's board of directors comprises two types of representatives: CREMECOMTRSBI inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CREMECOMTRSBI. The board's role is to monitor CREMECOMTRSBI's management team and ensure that shareholders' interests are well served. CREMECOMTRSBI's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CREMECOMTRSBI's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jan Salit, President Secretary
Frank Golay, Independent Director
Avi Shemesh, Director
Avraham Shemesh, Director
David Thompson, Chief Executive Officer
Robert Cresci, Independent Director
Kelly Eppich, Independent Director
Douglas Bech, Independent Director
Richard Ressler, Chairman of the Board
Shaul Kuba, Director
Nathan DeBacker, Chief Financial Officer

CREMECOMTRSBI Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CREMECOMTRSBI a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in CREMECOMTRSBI Stock

CREMECOMTRSBI financial ratios help investors to determine whether CREMECOMTRSBI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CREMECOMTRSBI with respect to the benefits of owning CREMECOMTRSBI security.